Holdings

Blue Owl Capital Holdings LP

As of Sep 30, 2026, Blue Owl Capital Holdings LP reported 48 positions worth US$544M. Largest: Space Exploration Technologies Corp, Aktis Oncology, Inc. and Latigo Biotherapeutics, Inc. What it bought and sold, with each filing.

Holdings

Positions
48
Value as reported
US$544M
Holdings as of
Sep 30, 2026
Last filed
Nov 13, 2026
CompanySharesValue as reported% of company% of portfolioChangeAs of
Space Exploration Technologies Corp
NASDAQ:SPCX
923KUS$139M0.01%25.4%−476KSep 30, 2026
Aktis Oncology, Inc.
NASDAQ:AKTS
3.34MUS$65.1M6.2%11.9%+274KSep 30, 2026
Latigo Biotherapeutics, Inc.
NASDAQ:LTGO
3.6MUS$60.1M5.4%11.0%NewSep 30, 2026
Larimar Therapeutics, Inc.
NASDAQ:LRMR
9.92MUS$31.7M9.5%5.8%+761KSep 30, 2026
Electra Therapeutics, Inc.
NASDAQ:ETRA
2.61MUS$29.4M4.2%5.4%NewSep 30, 2026
Nuveen Churchill Direct Lending Corp.
NYSE:NCDL
2.14MUS$24.1M4.4%4.4%No changeSep 30, 2026
Cullinan Therapeutics, Inc.
NASDAQ:CGEM
1.4MUS$21.5M3.9%−140KSep 30, 2026
Blue Owl Capital Corporation
NYSE:OBDC
2.05MUS$21.5M0.42%3.9%No changeSep 30, 2026
Obsidian Therapeutics, Inc.
NASDAQ:OBX
1.48MUS$20.4M2.4%3.7%NewSep 30, 2026
Sagimet Biosciences Inc. - Series A
NASDAQ:SGMT
1.13MUS$11.1M1.6%2.0%−135KSep 30, 2026
Dell Technologies Inc.
NYSE:DELL
19,342US$10.4M<0.01%1.9%−13,619Sep 30, 2026
Holley Inc.
NYSE:HLLY
4.38MUS$10.3M3.6%1.9%No changeSep 30, 2026
Conduent Incorporated
NASDAQ:CNDT
5.04MUS$7.86M3.2%1.4%No changeSep 30, 2026
Deep Fission, Inc.
NASDAQ:FISN
1.33MUS$6.84M2.3%1.2%No changeSep 30, 2026
Aquestive Therapeutics, Inc.
NASDAQ:AQST
1.39MUS$6.44M1.1%1.2%+448KSep 30, 2026
Immix Biopharma, Inc.
NASDAQ:IMMX
602KUS$6.26M0.72%1.1%+164KSep 30, 2026
MapLight Therapeutics, Inc.
NASDAQ:MPLT
556KUS$5.67M1.3%1.0%−174KSep 30, 2026
Veradermics, Incorporated
NYSE:MANE
45,000US$5.46M0.11%1.00%NewSep 30, 2026
ImageneBio, Inc.
NASDAQ:IMA
1.14MUS$5.2M9.1%0.95%+217KSep 30, 2026
Opus Genetics, Inc.
NASDAQ:IRD
970KUS$4.69M1.0%0.86%NewSep 30, 2026
Corvus Pharmaceuticals, Inc.
NASDAQ:CRVS
359KUS$4.13M0.43%0.75%−250KSep 30, 2026
Rezolute, Inc.
NASDAQ:RZLT
935KUS$3.87M0.97%0.71%NewSep 30, 2026
Artiva Biotherapeutics, Inc.
NASDAQ:ARTV
530KUS$3.77M1.1%0.69%−345KSep 30, 2026
Cybin, Inc.
NEO:HELP
288KUS$3.54M0.39%0.65%+228KSep 30, 2026
Achieve Life Sciences, Inc.
NASDAQ:ACHV
413KUS$3.34M0.38%0.61%NewSep 30, 2026
Procore Technologies, Inc.
NYSE:PCOR
64,030US$3.31M0.60%NewSep 30, 2026
Compass Therapeutics, Inc.
NASDAQ:CMPX
3.15MUS$3.28M1.8%0.60%−470KSep 30, 2026
Palvella Therapeutics, Inc.
NASDAQ:PVLA
23,003US$3.17M0.16%0.58%−13,256Sep 30, 2026
Zura Bio Limited
NASDAQ:ZURA
735KUS$3.06M0.56%NewSep 30, 2026
LENZ Therapeutics, Inc.
NASDAQ:LENZ
782KUS$3M2.5%0.55%+25,000Sep 30, 2026
Starwood Property Trust Inc.
NYSE:STWD
196KUS$2.65M0.05%0.48%No changeSep 30, 2026
Pyxis Oncology, Inc.
NASDAQ:PYXS
1MUS$2.33M0.84%0.43%NewSep 30, 2026
Viridian Therapeutics, Inc.
NASDAQ:VRDN
100KUS$2.06M0.38%−160KSep 30, 2026
Netskope, Inc.
NASDAQ:NTSK
97,148US$1.69M0.04%0.31%NewSep 30, 2026
ServiceTitan, Inc.
NASDAQ:TTAN
25,360US$1.67M0.30%NewSep 30, 2026
First Advantage Corporation
NASDAQ:FA
88,665US$1.58M0.29%NewSep 30, 2026
Eledon Pharmaceuticals, Inc.
NASDAQ:ELDN
567KUS$1.43M0.67%0.26%No changeSep 30, 2026
WW International, Inc.
NASDAQ:WW
71,277US$1.1M0.71%0.20%−13,122Sep 30, 2026
Marker Therapeutics, Inc.
NASDAQ:MRKR
554KUS$593K3.3%0.11%No changeSep 30, 2026
Fold Holdings, Inc.
NASDAQ:FLD
857KUS$454K1.6%0.08%No changeSep 30, 2026
Piper Sandler Companies
NYSE:PIPR
2,428US$160K<0.01%0.03%No changeSep 30, 2026
Caris Life Sciences, Inc.
NASDAQ:CAI
4,711US$144K<0.01%0.03%No changeSep 30, 2026
Energy Transfer LP
NYSE:ET
5,326US$105K<0.01%0.02%No changeSep 30, 2026
Vodafone Group Public Limited Company
LSE:VOD
5,371US$86,7690.02%No changeSep 30, 2026
Tactical Resources Corporation
NASDAQ:TREO
11,250US$29,8820.08%<0.01%NewSep 30, 2026
Monte Rosa Therapeutics, Inc.
NASDAQ:GLUE
2,392US$28,537<0.01%NewSep 30, 2026
AEON Biopharma, Inc.
AMEX:AEON
42,353US$12,7060.05%<0.01%No changeSep 30, 2026
Katapult Holdings, Inc.
NASDAQ:KPLT
5,421US$3,547<0.01%<0.01%No changeSep 30, 2026